FDA Preemption: Proposed Labeling Rule Draws Opposition From All Sides
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposal to restrict when companies can revise product labeling without first getting agency approval drew a sharp reaction from lawyers involved in product liability litigation